Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 1
Total trials 1

My Organizations' Clinical Trials

Showing 200 of 3033 entries
View as:

Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05584449 Org: User:
Start: 01/16/23 End: 10/18/25 Due: 10/18/26

DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine

Phase: N/A Priority: Normal
NCT ID: NCT06347809 Org: User:
Start: 01/23/19 End: 02/01/29 Due: 02/01/30

A Study of Entresto in Tetralogy of Fallot (TOF) and Ebstein's Anomaly (EA)

Phase: N/A Priority: Normal
NCT ID: NCT06693674 Org: User:
Start: 02/03/25 End: 12/31/26 Due: 12/31/27

Rapid Rehabilitation to Treat Lower Extremity Trauma

Phase: N/A Priority: Normal
NCT ID: NCT05225792 Org: User:
Start: 01/08/24 End: 09/30/26 Due: 09/30/27

Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03012880 Org: User:
Start: 04/20/17 End: 12/15/22 Due: 12/15/23

Quantitative Assessment of Painful Diabetic Peripheral Neuropathy After High Frequency Spinal Cord Stimulation

Phase: N/A Priority: Normal
NCT ID: NCT03769675 Org: User:
Start: 11/20/18 End: 04/15/22 Due: 04/15/23

Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders

Phase: N/A Priority: Normal
NCT ID: NCT05116943 Org: User:
Start: 08/19/13 End: 01/31/30 Due: 01/31/31

COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT04476953 Org: User:
Start: 08/03/20 End: 09/30/25 Due: 09/30/26

Endoscopic Full Thickness Biopsy, Gastric Wall.

Phase: N/A Priority: Normal
NCT ID: NCT01650714 Org: User:
Start: 09/30/12 End: 09/30/14 Due: 09/30/15

Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01269385 Org: User:
Start: 01/31/11 End: 06/30/15 Due: 06/30/16

Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache

Phase: N/A Priority: Normal
NCT ID: NCT04369729 Org: User:
Start: 09/09/20 End: 08/31/25 Due: 08/31/26

Complications Associated With Primary Placement of Gastrostomy for Feeding

Phase: N/A Priority: Normal
NCT ID: NCT05173935 Org: User:
Start: 12/08/17 End: 07/29/21 Due: 07/29/22

Lidocaine as an Endotracheal Tube (ETT) Cuff Media

Phase: N/A Priority: Normal
NCT ID: NCT03343080 Org: User:
Start: 07/27/18 End: 08/01/19 Due: 08/01/20

Individualized Preoperative Rehabilitation Pilot

Phase: N/A Priority: Normal
NCT ID: NCT02082223 Org: User:
Start: 03/31/14 End: 12/25/17 Due: 12/25/18

Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03469271 Org: User:
Start: 05/25/18 End: 05/21/20 Due: 05/21/21

Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04369703 Org: User:
Start: 01/28/20 End: 04/29/22 Due: 04/29/23

Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT01609335 Org: User:
Start: 07/31/12 End: 08/31/13 Due: 08/31/14

ANX-042 Healthy Volunteer Dose Escalation Study

Phase: N/A Priority: Normal
NCT ID: NCT01638104 Org: User:
Start: 08/31/12 End: 12/31/12 Due: 12/31/13

Spinal Morphine vs. Hydromorphone for Pain Control After Cesarean Delivery

Phase: N/A Priority: Normal
NCT ID: NCT02789410 Org: User:
Start: 05/31/16 End: 03/15/18 Due: 03/15/19

The Feasibility and Acceptability of Utilizing Telehealth for Increasing Access to Bariatric Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05678179 Org: User:
Start: 02/06/23 End: 03/27/24 Due: 03/27/25

Evaluation of 3D Surface Scanning for Virtual-CT Based Radiation Therapy Treatment Planning

Phase: N/A Priority: Normal
NCT ID: NCT06409000 Org: User:
Start: 01/19/21 End: 08/31/25 Due: 08/31/26

A Study of Ultra High Dose Diuretics to Treat Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT06036914 Org: User:
Start: 11/27/23 End: 10/08/24 Due: 10/08/25

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01767636 Org: User:
Start: 05/16/13 End: 01/20/21 Due: 01/20/22

A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis

Phase: N/A Priority: Normal
NCT ID: NCT05517928 Org: User:
Start: 03/03/23 End: 06/30/26 Due: 06/30/27

Using Facebook to Support Opioid Recovery Among American Indian Women

Phase: N/A Priority: Normal
NCT ID: NCT05995886 Org: User:
Start: 10/16/23 End: 12/31/25 Due: 12/31/26